Man and woman sitting a table drinking souvenaid

Support memory function in early Alzheimer's disease with Souvenaid®1-3

Backed by 20 years of research1-4

 

Souvenaid® is proven to slow memory and cognitive decline by an average of 60% in an early stage of Alzheimer’s disease known as mild cognitive impairment when taken daily for 3 years.3 Based on a study published in 2021. Individual results may vary.

 

 

The right nutrition is important to support the growth of brain connections.

However, research has shown that people with Alzheimer’s disease including MCI often have low levels of some key nutrients including folate, choline, omega-3 fatty acids, and vitamins A, C, E and B12.4,5

 

Souvenaid® is powered by Fortasyn® Connect, a unique combination of nutrients at levels difficult to achieve from normal dietary intake alone, formulated to support the growth of brain connections.6

 

It has been shown to be safe and well tolerated when used alone or alongside common Alzheimer's disease medications.1-3,7

 

 

Potential funding options for Souvenaid®     

Man and woman sitting on couch drinking Souvenaid

Potential funding available as part of Support at Home or by the NDIS

If you have a Support at Home package, speak to your provider or case manager about Souvenaid® today. 


Visit My Aged Care to learn more, or ask your doctor if you're eligible. Your doctor can also advise about other funding options through NDIS or DVA if a Support at Home Package isn't suitable. 

 

Eligibility criteria apply.*

 

 

 

Want to try before you buy? 

Have you been recommended Souvenaid® by your healthcare professional? Fill out the form to get a free sample delivered to your door. 

 

 

 

 

Learn more about Souvenaid®

 

 

 

 

 

 

Where to buy Souvenaid®

You can choose how you would like to buy Souvenaid®, depending on your preference. 

 

The options include buying direct online or over the phone, through major pharmacies nationwide, or through funding options mentioned above. 

 

 

 

Endorsed by Gerald Quigley

Souvenaid® is backed by 20 years of research1-4 and endorsed by Gerald Quigley, a community pharmacist with 50+ years of experience.

 

 

 

 

 

 

*Souvenaid® is included and can be funded as part of Support at Home if aligned with the patient’s identified needs and preferences and when recommended by a healthcare professional.  Souvenaid® can be funded by the NDIS if recommended by a healthcare professional as part of a treatment plan and considered a reasonable and necessary support directly related to the participant’s disability.

 

Souvenaid® is a food for special medical purposes and must be must under medical supervision. Souvenaid® does not cure or alleviate Alzheimer’s disease.

 

 

1 - Scheltens et al. Alzheimer’s Dement. 2010;6:1–10.e1.

 

2 - Scheltens et al. J Alzheimer’s Dis. 2012;31:225–36.

 

3 - Soininen et al. Alzheimer’s Dement. 2021;17:29–40.

 

4 - Mi et al. Nutrition. 2013;29(9):1080–9.

 

5 - van Wijk et al. Alzheimer’s Dement. 2017;8:139-46.

 

6 - Sijben et al. OCL. 2011:18;267-70.

 

7 - Shah et al. Alzheimer’s Res Ther. 2013;5:59.

x